Biweekly Follow-Up and At-Home Ultrasound Reduce Anxiety in Women With Recurrent Pregnancy Loss
Recurrent Pregnancy Loss
About this trial
This is an interventional supportive care trial for Recurrent Pregnancy Loss
Eligibility Criteria
Inclusion Criteria: Patients with recurrent pregnancy losses in first trimester Current pregnancy gestational age 12-14 week of gestation Singleton pregnancy Exclusion Criteria: Female subjects who refuse to participate Female subjects who don't speak Hebrew
Sites / Locations
- Departments of Obstetrics & Gynecology, affiliated with Sackler Faculty of Medicine, Tel Aviv UniversityRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Experimental: PulseNmore ES™
Control Standard Ultrasound
Experimental: PulseNmore ES™: The study population will be recruited between 12 and 14 weeks of gestation. These patients will be followed using a twice weekly virtual visit by a member of the study team. This visit will include a short survey of obstetrical complaints such as contractions leakage of fluid and decreased fetal movements, as well as a brief sonographic survey using the portable ultrasound device.
A population of patients between 12 and 22 weeks of gestation with history of recurrent pregnancy losses who will be subjected to routine antenatal care as per clinic protocol. These patients will not receive the additional intervention.